Eric Lefkofsky is a philanthropist, entrepreneur, co-founder and the CEO at Chicago based company, Tempus founded in the year 2015. He is also the founding partner of Lightbank firm that ventures in investing technology business and co-founder as well as chairperson of Groupon.
Tempus is a fast growing technology company which has built an operating system to fight against cancer disease. The primary mission is to redefine the use of genomic data in a clinical setting. As the company accumulates the collected data, treatment of patients who come afterward is advantageous since the physician got appropriate tools from the received data.
On a monthly basis, the start-up keeps expanding at a high rate where the company hires additional of 30 employees to its existing 400 workers. The high demand has however constituted the need for funding the company to stabilize its financial status. Therefore, raising $70 million round, the company after that received additional funds amounting to $80 million courtesy of new and existing investors, thus bringing Tempus to a total of $210 million. New investors who funded Tempus included T. Rowe and Kinship Trust Company.
The growth of Tempus Company has been driven by the new technology that has resulted in screening and risk identification of cancer. Learning extensively on tech machines, the doctors can then issue patients with treatment plans matching them with the clinical test, therapy selections, and medical development.
Erick Lefkofsky explained on Chicago new about the difficulties and challenges that faced the Tempus at its early stages, where it underwent through frustration on a health care system that would often let the essential data go to waste for no reason. He further reiterated on the company’s potentiality to introduce a new era of precision medicine to aid battling cancer when given a scale and breadth of current data-set.
The company has collaborated with other cancer research hospitals like the University of Chicago, Mayo Clinic, University of Michigan, Northwestern University, the Cleveland Clinic, School of Medicine, Duke University School of Medicine and Knight Cancer Institute in OHSU. Tempus currently works with almost half of all Medical Research Centers in U.S.